Surrey researchers Sign in
Development of a second-generation oncolytic Herpes simplex virus expressing TNF alpha for cancer therapy
Journal article

Development of a second-generation oncolytic Herpes simplex virus expressing TNF alpha for cancer therapy

ZQ Han, M Assenberg, BL Liu, YB Wang, G Simpson, S Thomas and RS Coffin
JOURNAL OF GENE MEDICINE, Vol.9(2), pp.99-106
01/02/2007

Abstract

Science & Technology Life Sciences & Biomedicine Biotechnology & Applied Microbiology Genetics & Heredity Medicine Research & Experimental Research & Experimental Medicine BIOTECHNOLOGY & APPLIED MICROBIOLOGY GENETICS & HEREDITY MEDICINE RESEARCH & EXPERIMENTAL TNF alpha oncolytic HSV cancer therapy TUMOR-NECROSIS-FACTOR GENE-THERAPY PHASE-I CELLS MUTANT PROMOTER TNFERADE IMMUNITY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245053000004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Details

Usage Policy